AP NEWS

Company Profile for Anova Enterprises, LLC

September 19, 2018

--(BUSINESS WIRE)--Sep 19, 2018--Anova Enterprises, LLC (Anova) is accelerating clinical development with an approach designed to disrupt and transform the traditional drug development model, using SaaS-based technology to enable efficient design, networking, management and conduct of clinical studies. The solution aligns the interests of all stakeholders (biopharmaceutical companies, medical device manufacturers and diagnostics companies, sites, principal investigators, Institutional Review Boards, ancillary service providers and patients), facilitates collaboration between these stakeholders and uses fact-based decision making to drive a learning system that speeds product development, reduces cost and increases the chance of product success (i.e., marketing approval).

View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005458/en/

KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Anova Enterprises, LLC

Copyright Business Wire 2018.

PUB: 09/19/2018 09:54 AM/DISC: 09/19/2018 09:54 AM

http://www.businesswire.com/news/home/20180919005458/en

AP RADIO
Update hourly